眼内容除去牙托粉球填充术的临床研究  

The study of polymethymethacrylate same term original sclera-encapsulated implant after evisceration

作　　者：张明欣[1] 敬海生[1] 彭力光[1] 郭晓晰[1] 

机构地区：[1]中国医科大学第八临床医学院鞍钢总医院眼科,鞍山114002

出　　处：《中国实用眼科杂志》2006年第1期98-99,共2页Chinese Journal of Practical Ophthalmology

摘　　要：目的观察眼内容除去术同期巩膜腔内牙托粉球（聚甲基丙烯酸甲酯，以后简称聚甲）填充术的效果。方法对1997年1月至2004年12月期间我科住院的备行眼球摘除的30例病人进行眼内容除去同期原巩膜腔内聚甲填充术。同时与同期间我科住院行眼球摘除的15例病人进行异体巩膜包裹羟基磷灰石（以后简称羟基）眼内填充术进行比较。结果聚甲组患者术后义眼活动自如，改善了眼窝塌陷外观，随访6个月～7年，未见填充球脱落、移位及眼眶炎症反应。结论聚甲基丙烯酸甲酯可应用于眼内填充。Objective To evaluate the clinical effect of polymethylmethaerylate same term original the sclera- encapsulated implant after evisceration. Methods 30 ophthahnic patients were going to be extirpate eyeball were implanted same term polymethylmethacrylate in the original sclera- encapsulated after evisceration （be called polymer for short later） during from Jan, 1997 to Dec, 2004, meanwhile, 15 patients were implanted hydroxyphosphorite in the rariant sclera- encapsulated after evisceration, the results were compared. Results All sockets of polymer patients have been corrected very well and the prosthetic mobility and the cosmetic appearance are excellent. After a follow up to 6 months to 7 years, no migration or extrusion of the implant or infection occurred. Conclusions Polymethylmethacrylate is wide - spread applied to intraocular implantation.

关 键 词：聚甲基丙烯酸甲酯 眼内容除去 原巩膜腔填充 

分 类 号：R779.6[医药卫生—眼科] R783.6[医药卫生—临床医学]